慢性乙型肝炎和乙型肝炎肝硬化患者胃粘膜病变研究

doi:10.3969/j.issn.1672-5069.2021.06.032

摘要/Abstract

摘要： 目的了解慢性乙型肝炎(CHB)和肝硬化患者胃粘膜病变发生率及其特征表现。方法 2017年1月～2019年1月海南医学院附属海南医院收治的70例慢性乙型肝炎、56例乙型肝炎肝硬化和同期在该院体检的50例健康人,接受胃镜检查,采用ELISA法检测血清胃蛋白酶原(PG)I和PGII水平,使用流式细胞仪检测外周血CD3⁺、CD4⁺和CD8⁺细胞百分比。结果乙型肝炎肝硬化组血清PGI水平(93.8±28.3)μg/L,显著低于健康人【(135.7±21.6)μg/L,P<0.05】或CHB患者【(116.3±32.4)μg/L,P<0.05】,血清PGII水平为(13.3±5.7)μg/L,显著高于健康人【(9.2±2.4)μg/L,P<0.05】,血清PGI/PGII比例为(7.1±2.3),显著低于健康人【(14.8±3.4),P<0.05】或CHB患者【(9.6±2.9),P<0.05】;健康人、CHB和肝硬化组浅表性胃炎发生率分别为68.0%、32.9%和19.6%,差异显著(P<0.05),肝硬化组轻、中、重度萎缩性胃炎发生率分别为37.5%、25.0%和17.9%,与健康人(分别为8.0%、6.0%和2.0%,P<0.05)或CHB组(分别为37.1%、11.4%和5.7%,P<0.05)比,差异显著;肝硬化组外周血CD3⁺细胞百分比为(62.4±7.9)%,显著低于健康人【(68.3±5.8)%,P<0.05】或CHB组【(66.4±7.4)%,P<0.05】,CD4⁺细胞百分比为(35.7±7.4)%,显著低于健康人【(50.3±6.6)%,P<0.05】或CHB组【(45.4±6.4)%,P<0.05】,而CD8⁺细胞百分比为(34.4±4.7)%,显著高于健康人【(27.2±4.3),P<0.05】,CD4⁺/CD8⁺细胞比值为(1.8±0.3),显著低于健康人【(2.8±0.9),P<0.05】。结论乙型肝炎肝硬化患者慢性萎缩性胃炎发生率高,血清PGI和PGII水平变化明显,其发生机制需要进一步探讨。

关键词: 肝硬化, 胃粘膜病变, 胃蛋白酶原

Abstract: Objective The aim of this study was to investigate gastric mucosal lesions in patients with hepatitis B and hepatitis B-induced liver cirrhosis. Methods 70 patients with chronic hepatitis B (CHB), 56 patients with liver cirrhosis and 50 healthy persons were enrolled in our hospital between January 2017 and January 2019, and all underwent gastroscopy. Serum PGI and PGII levels were detected by ELISA, and peripheral blood CD3⁺, CD4⁺ and CD8⁺ cells were detected by FCM. Results Serum PGI level in patients with hepatitis B-induced liver cirrhosis was(93.8±28.3)μg/L, significantly lower than [(135.7±21.6)μg/L, P<0.05] in healthy persons or [(116.3±32.4)μg/L, P<0.05] in patients with CHB, serum PGII level was (13.3±5.7)μg/L, significantly higher than [(9.2±2.4)μg/L, P<0.05] in healthy persons, and the ratio of serum PGI/PGII was (7.1±2.3), significantly lower than [(14.8±3.4), P<0.05] in healthy persons or [(9.6±2.9), P<0.05] in patients with CHB; the prevalences of chronic superficial gastritis in healthy persons, in patients with CHB and in patients with cirrhosis were 68.0%, 32.9% and 19.6%(P<0.05), and the incidences of mild, moderate and severe chronic atrophic gastritis in patients with cirrhosis were 37.5%, 25.0% and 17.9%, significantly different compared to 8.0%, 6.0% and 2.0% (P<0.05) in healthy persons or 37.1%, 11.4% and 5.7% (P<0.05) in patients with CHB; the percentage of peripheral blood CD3⁺ cells in patients with cirrhosis was (62.4±7.9)%, significantly lower than [(68.3±5.8)%, P<0.05] in healthy persons or [(66.4±7.4)%, P<0.05] in patients with cirrhosis, the percentage of CD4⁺ cells was (35.7±7.4)%, significantly lower than [(50.3±6.6)%, P<0.05] in healthy persons or [(45.4±6.4)%, P<0.05] in patients with CHB, while the percentage of CD8⁺ cells was (34.4±4.7)%, significantly higher than [(27.2±4.3), P<0.05] and the ratio of CD4⁺/CD8⁺ cells was (1.8±0.3), significantly lower than [(2.8±0.9), P<0.05] in healthy persons. Conclusion The chronic atrophic gastritis in patients with hepatitis B cirrhosis is common, serum PGI and PGII levels change obviously, and the mechanism involved needs further investigation.

Key words: Liver cirrhosis, Gastric mucosal lesions, Pepsinogen

韩利畴, 许望, 韩丹, 邢增珀. 慢性乙型肝炎和乙型肝炎肝硬化患者胃粘膜病变研究[J]. 实用肝脏病杂志, 2021, 24(6): 895-898.

Han Lichou, Xu Wang, Han Dan, et al. Observation of gastric mucosal lesions in patients with hepatitis B liver cirrhosis[J]. Journal of Practical Hepatology, 2021, 24(6): 895-898.

参考文献

[1] Han X, Huang T, Han J. Cytokines derived from innate lymphoid cells assist helicobacter hepaticus to aggravate hepatocellular tumorigenesis in viral transgenic mice. Gut Pathog, 2019,11:23.
[2] 赵蕾, 李小丹, 刘淼. 拉米夫定与替比夫定阻断乙型肝炎病毒宫内感染的疗效和风险分析. 实用肝脏病杂志, 2020, 23(4): 496-499.
[3] Zhao SX, Li WC, Fu N, et al. Emperipolesis mediated by CD8⁺ T cells correlates with biliary epithelia cell injury in primary biliary cholangitis. J Cell Mol Med, 2020,24(2):1268-1275.
[4] Xuan ZH, Wang LH, Ling ZY, et al. Hepatitis B virus X protein modulates renal tubular epithelial cell-induced T-cell and macrophage responses. Immunol Cell Biol, 2015, 94(3):266-273.
[5] Boltjes A, Brouw ML, Biesta PJ, et al. Assessment of the effect of ribavirin on myeloid and plasmacytoid dendritic cells during interferon-based therapy of chronic hepatitis B patients. Mol Immunol, 2013,53(1-2):72-78.
[6] Morisawa T, Namikawa M, Umeda M. Gastric emphysema with hepatic portal venous gas secondary to acute gastric mucosal lesion. Clin Gastroenterol Hepatol, 2020,S1542-3565(20):30970-30978.
[7] Kim Y S, Lee J H, Song J, et al. Gastroprotective effects of inulae flos on hcl/ethanol-induced gastric ulcers in rats. Molecules, 2020, 25(23):5623.
[8] Tu H, Sun L, Dong X, et al. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study. Int J Cancer, 2015,136(2):425-434.
[9] Wang X, Lu B, Meng L, et al. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China. Scand J Gastroenterol,2017,52(8):822-827.
[10] 陈红英, 丁洁, 游晶,等. 慢性乙型肝炎病毒感染者血清流行病学研究. 中国全科医学, 2017, 8(10):54-57,62.
[11] 孙雪飞, 何旭. 慢性萎缩性胃炎的胃镜下表现与病理诊断. 实用临床医药杂志, 2017(1):194-202.
[12] Behairy BE, Nermine E, Magdy A, et al. Expression of intrahepatic CD3, CD4, and CD8 T cells in biliary atresia. Clin Exp Hepatol,2018, 4(1):7-12.
[13] Nakiboneka R, Mugaba S, Auma BO, et al. Interferon gamma (IFN-γ) negative CD4⁺ and CD8⁺ T-cells can produce immune mediators in response to viral antigens. Vaccine,2019,37(1):113-122.
[14] 樊巧, 冯红军, 周环宇,等. 慢性乙型肝炎患者胃黏膜损伤中胃黏液sIgA的变化研究. 中华医院感染学杂志, 2016, 26(17):3892-3894.
[15] Carrilho FJ, Mattos AA, Vianey AF, et al. Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinoma. Arq Gastroenterol, 2015,52(Suppl 1):2-14.
[16] Hashimoto K, Suzuki A M, Santos A D, et al. CAGE profiling of ncRNAs in hepatocellular carcinoma reveals widespread activation of retroviral LTR promoters in virus-induced tumors. Genome Res, 2015, 25(12):1812-1824.
[17] Jie P, Jing Z, Qi FZ, et al. A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma. Diagn Interv Radio, 2018, 24(3):121-127.
[18] Dang SC, Wang H, Zhang JX, et al. Are gastric mucosal macrophages responsible for gastric injury in acute pancreatitis? World J Gastroenterol,2015, 21(9):2651-2657.
[19] Masullo M, Mari A, Cerulli A, et al. Quali-quantitative analysis of the phenolic fraction of the flowers of Corylus avellana, source of the Italian PGI product "Nocciola di Giffoni": Isolation of antioxidant diarylheptanoids. Phytochemistry, 2016,130:273-281.
[20] Muhsen K, Sinnreich R, Merom D, et al. Prevalence and determinants of serological evidence of atrophic gastritis among Arab and Jewish residents of Jerusalem: a cross-sectional study. BMJ Open, 2019,9(1):e024689.
[21] Zoalfaghari A, Aletaha N, Roushan N, et al. Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population.Med J Islam Repub Iran, 2014, 28(1):150-150.